Anti-PZP/ CPAMD6 functional antibody
Anti-PZP/ CPAMD6 functional antibody for cell culture, ELISA & in-vivo assay
Go to PZP/PZP products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-SE1232-Ab-1/ GM-Tg-hg-SE1232-Ab-2 | Anti-Human PZP monoclonal antibody | Human |
GM-Tg-rg-SE1232-Ab-1/ GM-Tg-rg-SE1232-Ab-2 | Anti-Rat PZP monoclonal antibody | Rat |
GM-Tg-mg-SE1232-Ab-1/ GM-Tg-mg-SE1232-Ab-2 | Anti-Mouse PZP monoclonal antibody | Mouse |
GM-Tg-cynog-SE1232-Ab-1/ GM-Tg-cynog-SE1232-Ab-2 | Anti-Cynomolgus/ Rhesus macaque PZP monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-SE1232-Ab-1/ GM-Tg-felg-SE1232-Ab-2 | Anti-Feline PZP monoclonal antibody | Feline |
GM-Tg-cang-SE1232-Ab-1/ GM-Tg-cang-SE1232-Ab-2 | Anti-Canine PZP monoclonal antibody | Canine |
GM-Tg-bovg-SE1232-Ab-1/ GM-Tg-bovg-SE1232-Ab-2 | Anti-Bovine PZP monoclonal antibody | Bovine |
GM-Tg-equg-SE1232-Ab-1/ GM-Tg-equg-SE1232-Ab-2 | Anti-Equine PZP monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-SE1232-Ab-1/ GM-Tg-hg-SE1232-Ab-2; GM-Tg-rg-SE1232-Ab-1/ GM-Tg-rg-SE1232-Ab-2; GM-Tg-mg-SE1232-Ab-1/ GM-Tg-mg-SE1232-Ab-2; GM-Tg-cynog-SE1232-Ab-1/ GM-Tg-cynog-SE1232-Ab-2; GM-Tg-felg-SE1232-Ab-1/ GM-Tg-felg-SE1232-Ab-2; GM-Tg-cang-SE1232-Ab-1/ GM-Tg-cang-SE1232-Ab-2; GM-Tg-bovg-SE1232-Ab-1/ GM-Tg-bovg-SE1232-Ab-2; GM-Tg-equg-SE1232-Ab-1/ GM-Tg-equg-SE1232-Ab-2 |
Products Name | Anti-PZP monoclonal antibody |
Format | mab |
Target Name | PZP |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-PZP benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-SE1232-Ag-1 | Recombinant multi-species PZP/ CPAMD6 protein |
Target information
Target ID | GM-SE1232 |
Target Name | PZP |
Gene ID | 5858,101080718 |
Gene Symbol and Synonyms | CPAMD6,PZP |
Uniprot Accession | P20742 |
Uniprot Entry Name | PZP_HUMAN |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | |
Disease | gynaecological tumors, Malignant neoplasm of bladder |
Gene Ensembl | ENSG00000126838 |
Target Classification | N/A |
The target: PZP, gene name: PZP, also named as CPAMD6. The protein encoded by this gene is highly expressed in late-pregnancy serum and is similar in structure to alpha-2-macroglobulin. The encoded protein, which acts as a homotetramer, inhibits the activity of all four classes of proteinases. This protein contains cleavage sites for several proteinases. Upon binding of a proteinase, the conformation of this protein changes to trap the proteinase, limiting its activity. This protein appears to be elevated in the sera of presymptomatic Alzheimer's disease patients. [provided by RefSeq, Dec 2016].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.